Hydrocortison Ace Pharmaceuticals Bv (Hydrocortisone)

Hydrocortison Ace Pharmaceuticals Bv is generally applied to the external ear canal to address inflammatory or allergic conditions where a localized corticosteroid effect is desired.

• Mild to moderate otitis externa with accompanying inflammation.
• Allergic or irritant dermatitis of the external auditory canal.
• Eczematous skin changes affecting the ear pinna or canal.
• Pruritus (itching) of the ear caused by dermatologic irritation.
• Post‑procedural inflammation following ear cleaning or minor surgery.
• Inflammatory response to preservative-containing ear drops.
• Localized swelling of the ear canal associated with eczema flare.

• Hydrocortisone exerts its anti‑inflammatory action by binding to intracellular glucocorticoid receptors. The drug‑receptor complex translocates to the nucleus, where it interacts with glucocorticoid response elements and alters transcription of multiple genes. This results in decreased synthesis of pro‑inflammatory cytokines, inhibition of phospholipase A2, and reduced production of prostaglandins and leukotrienes, collectively suppressing local immune and inflammatory responses in the ear tissue.

Local application of hydrocortisone to the ear may be associated with a range of adverse reactions, most of which are mild and reversible.

Common

• Transient itching or burning sensation at the application site.
• Mild dryness or flaking of the ear canal skin.
• Localized erythema or mild redness.
• Temporary feeling of fullness or pressure in the ear.
• Mild swelling of the ear canal that resolves after discontinuation.

Serious

• Signs of secondary bacterial or fungal infection, such as increased discharge or foul odor.
• Severe allergic reaction manifested by swelling, hives, or difficulty breathing.
• Significant thinning of the skin leading to ulceration or perforation of the tympanic membrane.

When using Hydrocortison Ace Pharmaceuticals Bv, certain precautions should be observed to minimize risks and ensure safe application in the ear.

• Avoid prolonged use beyond the period recommended by a healthcare professional.
• Do not apply to a ruptured tympanic membrane or active ear infection without medical guidance.
• Limit use in patients with known hypersensitivity to hydrocortisone or other corticosteroids.
• Exercise caution in individuals with diabetes, glaucoma, or cataracts, as systemic absorption may affect these conditions.
• Pregnancy and breastfeeding status should be discussed with a clinician before initiating therapy.
• Store the product at room temperature, protected from moisture and direct sunlight.

Hydrocortisone ear preparations can interact with other medications or substances applied to the same area, potentially altering efficacy or safety.

Avoid

• Concurrent use of other topical antibiotics or antifungals without physician direction, as combined effects may increase irritation.
• Application of otic preparations containing strong acids, bases, or alcohol, which can degrade the corticosteroid.
• Use of otic decongestants containing vasoconstrictors, which may reduce drug absorption.

Use with caution

• Systemic corticosteroids, because additive immunosuppressive effects may increase infection risk.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied locally, which may heighten local irritation.
• Ear drops containing preservatives, which could potentiate allergic reactions.
• Patients using systemic immunosuppressants should be monitored for increased susceptibility to ear infections.